- Home
- CLPS vs PULM Comparison
CLPS vs PULM Comparison
Compare CLPS & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- PULM
- Stock Information
- Founded
- CLPS 2005
- PULM 2003
- Country
- CLPS Hong Kong
- PULM United States
- Employees
- CLPS N/A
- PULM N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- CLPS Technology
- PULM Health Care
- Exchange
- CLPS Nasdaq
- PULM Nasdaq
- Market Cap
- CLPS 26.0M
- PULM 33.2M
- IPO Year
- CLPS 2018
- PULM N/A
- Fundamental
- Price
- CLPS $0.92
- PULM $6.56
- Analyst Decision
- CLPS
- PULM
- Analyst Count
- CLPS 0
- PULM 0
- Target Price
- CLPS N/A
- PULM N/A
- AVG Volume (30 Days)
- CLPS 12.0K
- PULM 60.4K
- Earning Date
- CLPS 03-05-2025
- PULM 08-12-2025
- Dividend Yield
- CLPS 14.23%
- PULM N/A
- EPS Growth
- CLPS N/A
- PULM N/A
- EPS
- CLPS N/A
- PULM N/A
- Revenue
- CLPS $153,816,045.00
- PULM $1,921,000.00
- Revenue This Year
- CLPS N/A
- PULM N/A
- Revenue Next Year
- CLPS N/A
- PULM $134.88
- P/E Ratio
- CLPS N/A
- PULM N/A
- Revenue Growth
- CLPS 5.81
- PULM N/A
- 52 Week Low
- CLPS $0.68
- PULM $1.78
- 52 Week High
- CLPS $1.70
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- CLPS 42.59
- PULM 40.87
- Support Level
- CLPS $0.90
- PULM $6.51
- Resistance Level
- CLPS $0.94
- PULM $6.96
- Average True Range (ATR)
- CLPS 0.05
- PULM 0.89
- MACD
- CLPS -0.00
- PULM -0.13
- Stochastic Oscillator
- CLPS 25.90
- PULM 42.38
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).